Local 12: Trial looks at treating pneumonia associated with COVID-19
Study examines anti-viral medication that could help reduce common complication of the coronavirus
A breakthrough trial is looking at a new anti-viral medication that could help reduce one of the most common complications of the COVID-19 coronavirus: pneumonia.
This new trial is one of a handful across the country looking at an antiviral therapy intended to stop the spread of this virus.
A team at the University of Cincinnati is conducting this research. Brett Kissela, MD, senior associate dean of clinical research at the UC College of Medicine and UC Health physician, is featured.
Read more about UC-led clinical trials.
Featured photo/Colleen Kelley/UC Creative + Brand
Related Stories
News Cincinnati loved in 2025
January 2, 2026
The story of prohibition bootlegger George Remus was among WLWT's favorite segments in 2025. UC Law Professor Christopher Bryant spoke with journalist Lindsay Stone about Remus using a temporary insanity defense during a murder trial.
What to know about this year’s big tax changes
January 2, 2026
Local 12 reported that taxpayers can expect some major changes this tax season. Gary Friedhoff, adjunct instructor at the University of Cincinnati’s Carl H. Lindner College of Business, recently spoke to Local 12 about how to avoid surprises.
Study finds police officers face higher long-term health risks
January 2, 2026
J.C. Barnes, a University of Cincinnati professor, is interviewed by Spectrum News about new research showing that the physical and psychological demands of law enforcement can contribute to earlier deaths.